Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Zenith Drugs Ltd

NSE: ZENITHDRUG · Pharmaceuticals & Biotechnology · 21 announcements

Share price
₹42.15
Market cap
₹72.28 Cr
Revenue (annual)
₹171.2 Cr
Net profit (annual)
₹3.94 Cr
P/E (TTM)
18.3×Sector 47.4×
Promoter holding
69.98%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:13 IST NSE
Annual General Meeting

Zenith Drugs Annual General Meeting

Zenith Drugs Limited has issued a notice for its 26th Annual General Meeting scheduled for September 29, 2026, to transact various ordinary and special business.

13:07 IST NSE
Board Meeting Outcome

Zenith Drugs Board Meeting Outcome

Zenith Drugs Limited announced the notice for its 26th AGM and appointed a secretarial auditor and a scrutinizer for the meeting.

13:10 IST NSE
Capital Structure Change

Zenith Drugs Capital Structure Change

Zenith Drugs Limited's board approved the allotment of 16,09,050 convertible warrants to promoters on a preferential basis. The aggregate consideration for this issuance is Rs. 6.99 Crore.

Value
₹7.00 Cr
15:55 IST NSE
Annual General Meeting

Zenith Drugs Annual General Meeting

Zenith Drugs Limited held an EGM on July 23, 2026. Members considered the issuance of up to 16,09,050 fully convertible warrants to promoters.

19:10 IST NSE
Annual General Meeting

Zenith Drugs Annual General Meeting

Zenith Drugs issued a corrigendum to its EGM notice scheduled for July 23, 2026. Updates include details on a Rs. 36.58 Crore term loan and shareholding changes.

Value
₹36.58 Cr